NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click to download the brief “Monoclonal antibodies provided benefits to vulnerable populations and six different ones were authorized to treat COVID-19,” said Dr. Wayne Winegarden, ...
NEW BRIEF: End Anti-Market Distortions in Current PBM System Would Lower Patient Costs, Increase Access to Life-Saving Drugs
SACRAMENTO – Fixing the current broken system that incentivizes pharmacy benefit managers (PBMs) to enact policies that benefit themselves and insurers at the expense of patients would lead to lower patient drug costs, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click to download the brief “The current system incentivizes PBMs to implement policies that benefit insurers and themselves, while making drugs less ...
Biden has given us worse healthcare
President Joe Biden proudly touted his record on healthcare during last month’s disastrous presidential debate. “The American public has greater healthcare coverage today than ever before,” he proclaimed. That’s debatable, to say the least. His administration’s policies have caused health insurance costs to surge. Biden began his presidency by increasing public subsidies for coverage through the exchanges. The Democrats have since extended those subsidies under the 2022 Inflation Reduction Act through 2025. They guarantee no one has to pay more than 8.5% ...
Trending Topics
Studies
